레이와트

ABOUT US

We innovate cardiovascular OCT devices to
improve the lives of patients worldwide.

Introduction

About us

About us_mobile
gap
  • Raywatt.Inc
  • We are innovating cardiovascular OCT medical
    devices
    for the lives of patients all over the world
    suffering from cardiovascular diseases.

    Raywatt is a world-leading company in the field of intravascular Optical Coherence Tomography (OCT) technology. We provide precise 2D/3D imaging through world-leading imaging technology of 400 frames per second, reducing contrast agent usage during OCT imaging to minimize patient side effects and complications. Additionally, our AI-powered FFR simulator aids accurate decision-making during medical procedures.

    In 2019, a group of experts in medicine, computer engineering, mechanical engineering, and optics came together to innovate in the field of intravascular OCT technology, thus founding Raywatt. After years of research and collaboration, we have developed the industry's top-performing intravascular OCT equipment, providing high-resolution cross-sectional images of blood vessels for enhanced diagnosis and treatment.

    At this moment, cardiovascular diseases remain the number one cause of death worldwide. We are committed to pushing the boundaries of OCT technology to ensure that all patients with cardiovascular diseases receive the best possible treatment.

    Raywatt promises an unwavering passion and expertise in advancing cardiovascular medicine. We always remember the vital role we play in the fight against cardiovascular diseases and will continually strive to help patients worldwide find a healthier future.

circle_line
rotary

History

  • 2025
    • 02
    • Secured Series A investment from IBK Industrial Bank of Korea / SBI Investment / L&S Venture Capital / Re-Investment
    • 01
    • Selected as an Innovative Startup by IBK ChangGong (創工)
  • 2024
    • 12
    • Secured Series A investment from Korea Investment Partners
    • 11
    • Completed product certification for Chouette optical fiber catheter (Certificate No. 24-1061)
    • 10
    • Received the 2024 KHF Innovation Award – Minister of Health and Welfare Award
    • Added RV200 model to Telemetry system transmitter, analysis lineup
    • 09
    • Obtained medical device GMP certification (Category: Catheters and Drainage Tubes for Medical Use (I))
    • 06
    • Won the 2024 Red Dot Award in the Design Concept category
    • 04
    • Selected for the Super-Gap Startup Development Program (DIPS 1000+)
    • Expanded and relocated the office to Seongsu-dong
    • 02
    • Secured investment from Sejong Angel Investment Association
  • 2023
    • 09
    • Prototype production of Raywatt FASTER OCT completed
    • 06
    • Secured Pre-A investment from Boditech Med Inc.
    • 04
    • Start-up Advancement Package Support Program
    • 03
    • Completed product certification for RV100 Telemetry system transmitter, analysis (Certificate No. 23-4567)
  • 2022
    • 12
    • Pre-A investment attraction from Korea Investment Partners
    • 06
    • Obtained GMP certification (Physiological Monitoring Device category)
    • Certified as a venture company
    • 05
    • Corporate R&D center established
    • Secured angel investment
  • 2019
    • 07
    • Raywatt incorporation established
  • 2017
    • 09
    • Selected for the MSIT Bio & Medical Technology Development Program (NRF grant: $2.7M)

CEO

Partners

  • 한국투자파트너스
  • Bio Technology
  • 세브란스 심장혈관병원

Raywatt is looking for partners to help commercialize our in-house
light imaging technologies.
We have applied for important patents
regarding OCT imaging systems, rotary junctions, and
catheters, and some of them have been granted.
We are ready to learn about your interests.

Raywatt

15F, Hyundai Terrace Tower West,
7, Yeonmujang 5ga-gil, Seongdong-gu, Seoul 04782,
Republic of Korea

+82-2-3409-4174 info@raywatt.com CopyrightⓒRaywatt Inc. All rights reserved made by chairone

Raywatt